Cargando…
Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study
BACKGROUND & OBJECTIVES: Age related macular degeneration (ARMD) is a leading cause of blindness, particularly in persons above 60 yr of age. Homocysteine is implicated in many ocular diseases including ARMD. This study was undertaken to assess the status and relationship between plasma homocyst...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094115/ https://www.ncbi.nlm.nih.gov/pubmed/27748300 http://dx.doi.org/10.4103/0971-5916.192026 |
_version_ | 1782465064248279040 |
---|---|
author | Bharathselvi, Muthuvel Biswas, Sayantan Raman, Rajiv Selvi, Radhakrishnan Coral, Karunakaran Narayanansamy, Angayarkanni Ramakrishnan, Sivaramakrishnan Sulochana, Konerirajapuram N. |
author_facet | Bharathselvi, Muthuvel Biswas, Sayantan Raman, Rajiv Selvi, Radhakrishnan Coral, Karunakaran Narayanansamy, Angayarkanni Ramakrishnan, Sivaramakrishnan Sulochana, Konerirajapuram N. |
author_sort | Bharathselvi, Muthuvel |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: Age related macular degeneration (ARMD) is a leading cause of blindness, particularly in persons above 60 yr of age. Homocysteine is implicated in many ocular diseases including ARMD. This study was undertaken to assess the status and relationship between plasma homocysteine, homocysteine - thiolactone, homocysteinylated protein and copper levels in patients with ARMD. METHODS: A total of 16 patients with ARMD and 16 age-matched controls were recruited for the study. Plasma glutathione, homocysteine, homocysteine - thiolactone and extent of homocysteine conjugation with proteins, copper and thiobarbituric acid reactive substances were measured. RESULTS: Homocysteine levels were elevated with increase in homocysteine-thiolactone, thiobarbituric acid reactive substances and a decrease of glutathione. The levels of homocysteinylated protein were elevated in ARMD. The elevated homocysteine, homocysteine-thiolactone correlated with the decrease in copper level. INTERPRETATION & CONCLUSIONS: Elevated homocysteine and its metabolite homocysteine-thiolactone and decreased levels of copper may play an important role in the pathogenesis of ARMD. |
format | Online Article Text |
id | pubmed-5094115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-50941152016-11-23 Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study Bharathselvi, Muthuvel Biswas, Sayantan Raman, Rajiv Selvi, Radhakrishnan Coral, Karunakaran Narayanansamy, Angayarkanni Ramakrishnan, Sivaramakrishnan Sulochana, Konerirajapuram N. Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Age related macular degeneration (ARMD) is a leading cause of blindness, particularly in persons above 60 yr of age. Homocysteine is implicated in many ocular diseases including ARMD. This study was undertaken to assess the status and relationship between plasma homocysteine, homocysteine - thiolactone, homocysteinylated protein and copper levels in patients with ARMD. METHODS: A total of 16 patients with ARMD and 16 age-matched controls were recruited for the study. Plasma glutathione, homocysteine, homocysteine - thiolactone and extent of homocysteine conjugation with proteins, copper and thiobarbituric acid reactive substances were measured. RESULTS: Homocysteine levels were elevated with increase in homocysteine-thiolactone, thiobarbituric acid reactive substances and a decrease of glutathione. The levels of homocysteinylated protein were elevated in ARMD. The elevated homocysteine, homocysteine-thiolactone correlated with the decrease in copper level. INTERPRETATION & CONCLUSIONS: Elevated homocysteine and its metabolite homocysteine-thiolactone and decreased levels of copper may play an important role in the pathogenesis of ARMD. Medknow Publications & Media Pvt Ltd 2016-06 /pmc/articles/PMC5094115/ /pubmed/27748300 http://dx.doi.org/10.4103/0971-5916.192026 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Bharathselvi, Muthuvel Biswas, Sayantan Raman, Rajiv Selvi, Radhakrishnan Coral, Karunakaran Narayanansamy, Angayarkanni Ramakrishnan, Sivaramakrishnan Sulochana, Konerirajapuram N. Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study |
title | Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study |
title_full | Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study |
title_fullStr | Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study |
title_full_unstemmed | Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study |
title_short | Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study |
title_sort | homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - a pilot study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094115/ https://www.ncbi.nlm.nih.gov/pubmed/27748300 http://dx.doi.org/10.4103/0971-5916.192026 |
work_keys_str_mv | AT bharathselvimuthuvel homocysteineitsmetabolitehomocysteinethiolactonedeficiencyofcopperinpatientswithagerelatedmaculardegenerationapilotstudy AT biswassayantan homocysteineitsmetabolitehomocysteinethiolactonedeficiencyofcopperinpatientswithagerelatedmaculardegenerationapilotstudy AT ramanrajiv homocysteineitsmetabolitehomocysteinethiolactonedeficiencyofcopperinpatientswithagerelatedmaculardegenerationapilotstudy AT selviradhakrishnan homocysteineitsmetabolitehomocysteinethiolactonedeficiencyofcopperinpatientswithagerelatedmaculardegenerationapilotstudy AT coralkarunakaran homocysteineitsmetabolitehomocysteinethiolactonedeficiencyofcopperinpatientswithagerelatedmaculardegenerationapilotstudy AT narayanansamyangayarkanni homocysteineitsmetabolitehomocysteinethiolactonedeficiencyofcopperinpatientswithagerelatedmaculardegenerationapilotstudy AT ramakrishnansivaramakrishnan homocysteineitsmetabolitehomocysteinethiolactonedeficiencyofcopperinpatientswithagerelatedmaculardegenerationapilotstudy AT sulochanakonerirajapuramn homocysteineitsmetabolitehomocysteinethiolactonedeficiencyofcopperinpatientswithagerelatedmaculardegenerationapilotstudy |